Long‐term management of vulval lichen sclerosus in adult women
The authors declare no conflict of interest.Dr J. Bradford and Dr G. Fischer equally contributed to the construction, analysis and writing of this study.
Abstract
Background: Adult vulval lichen sclerosus (VLS) is usually a lifelong disease with an estimated remission rate after treatment of only 16% [Arch Dermatol 2004; 140 (6): 709]. Although superpotent topical corticosteroid (TCS) is the validated gold standard treatment to induce remission, little data are available on how remission should be maintained.
Aims: We present a retrospective chart review of 129 adult patients with VLS who have been under surveillance by the authors for a minimum duration of three years.
Methods: Remission was maintained in most patients with low‐to‐moderate potency TCS. All subjects’ symptoms, signs, treatment regimes and response to treatment including compliance, symptom remission, disease progression with scarring, squamous cell carcinoma and side effects were recorded. Data were compared for the compliant and non‐compliant groups. Fischer’s exact test was used to identify significant differences.
Results: The mean age at presentation was 53.6 years and mean duration of follow‐up was 6.2 years. Compliance was excellent: 84 (65%) of patients’ self‐reporting as being fully compliant. Symptom remission was achieved in 98% of compliant and 75% of non‐compliant patients (P = 0.001) Progression of disease with scarring was not encountered in any of the compliant patients, but was seen in 35% of non‐compliant patients (P = 0.0001). One patient had squamous cell carcinoma on first presentation. Carcinoma subsequently occurred in none of the compliant patients, and in five partly compliant patients (P = 0.004). Mild, reversible corticosteroid side effects were encountered in 7% of patients.
Conclusions: Long‐term treatment of adult VLS with individualised regimes using moderate potency TCS is safe and effective. Patients require long‐term follow‐up.
Number of times cited: 31
- Rachel Pounds, Sanna Tahir, Christopher Dawson, Ciaran Woodman, David Luesley and Jason Yap, A survey on the use of topical steroids in patients treated for lichen sclerosus-associated vulval squamous cell carcinoma, Journal of Obstetrics and Gynaecology, 38, 2, (265), (2018).
- Michal Sheinis and Amanda Selk, Development of the Adult Vulvar Lichen Sclerosus Severity Scale—A Delphi Consensus Exercise for Item Generation, Journal of Lower Genital Tract Disease, 10.1097/LGT.0000000000000361, 22, 1, (66-73), (2018).
- Agnieszka Maździarz, Beata Osuch, Magdalena Kowalska, Agnieszka Nalewczyńska and Beata Śpiewankiewicz, Photodynamic therapy in the treatment of vulvar lichen sclerosus, Photodiagnosis and Photodynamic Therapy, 19, (135), (2017).
- Moniek M. ter Kuile and Katja N. Gaarenstroom, A Woman with Changing Vulvar Anatomy: Sexuality in Women with Lichen Sclerosus, Bio-Psycho-Social Obstetrics and Gynecology, 10.1007/978-3-319-40404-2_19, (329-341), (2017).
- Tania Day, Sarah Moore, Tanja Gizela Bohl and James Scurry, Comorbid Vulvar Lichen Planus and Lichen Sclerosus, Journal of Lower Genital Tract Disease, 10.1097/LGT.0000000000000307, 21, 3, (204-208), (2017).
- Tania Day, Ailsa Borbolla Foster, Samuel Phillips, Ross Pagano, Delwyn Dyall-Smith, James Scurry and Suzanne M. Garland, Can Routine Histopathology Distinguish Between Vulvar Cutaneous Candidosis and Dermatophytosis?, Journal of Lower Genital Tract Disease, 20, 3, (267), (2016).
- Leonardo Micheletti, Mario Preti, Gianluigi Radici, Sara Boveri, Orazio Di Pumpo, Sebastiana S. Privitera, Bruno Ghiringhello and Chiara Benedetto, Vulvar Lichen Sclerosus and Neoplastic Transformation, Journal of Lower Genital Tract Disease, 10.1097/LGT.0000000000000186, 20, 2, (180-183), (2016).
- Andrew Lee, Adrian Lim and Gayle Fischer, Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus, Australasian Journal of Dermatology, 57, 1, (39-43), (2015).
- Tania Day, Tanja Gizela Bohl and James Scurry, Perianal lichen dermatoses: A review of 60 cases, Australasian Journal of Dermatology, 57, 3, (210-215), (2015).
- Tania Day, Nikola Bowden, Ken Jaaback, Geoff Otton and James Scurry, Distinguishing Erosive Lichen Planus From Differentiated Vulvar Intraepithelial Neoplasia, Journal of Lower Genital Tract Disease, 20, 2, (174), (2016).
- A. Borghi, M. Corazza, S. Minghetti, G. Toni and A. Virgili, Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: results of a randomized trial, British Journal of Dermatology, 173, 6, (1381-1386), (2015).
- A. Borghi, M. Corazza, S. Minghetti, G. Toni and A. Virgili, Avocado and soybean extracts as active principles in the treatment of mild‐to‐moderate vulvar lichen sclerosus: results of efficacy and tolerability, Journal of the European Academy of Dermatology and Venereology, 29, 6, (1225-1230), (2014).
- G. Kirtschig, K. Becker, A. Günthert, D. Jasaitiene, S. Cooper, C.‐C. Chi, A. Kreuter, K.K. Rall, W. Aberer, S. Riechardt, F. Casabona, J. Powell, F. Brackenbury, R. Erdmann, M. Lazzeri, G. Barbagli and F. Wojnarowska, Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus, Journal of the European Academy of Dermatology and Venereology, 29, 10, (e1-e43), (2015).
- Ahmed Samy El-agwany, Extensive anogenital lichen sclerosus with vaginal stenosis: A case report, Journal of Dermatology & Dermatologic Surgery, 19, 2, (140), (2015).
- Anne N. Flynn, Michelle King, Mollie Rieff, Jill Krapf and Andrew T. Goldstein, Patient Satisfaction of Surgical Treatment of Clitoral Phimosis and Labial Adhesions Caused by Lichen Sclerosus, Sexual Medicine, 3, 4, (251-255), (2015).
- Elizabeth Ellis and Gayle Fischer, Prepubertal‐Onset Vulvar Lichen Sclerosus: The Importance of Maintenance Therapy in Long‐Term Outcomes, Pediatric Dermatology, 32, 4, (461-467), (2015).
- A. Virgili, A. Borghi, G. Toni, S. Minghetti and M. Corazza, First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability, British Journal of Dermatology, 171, 2, (388-396), (2014).
- A. Virgili, A. Borghi, S. Minghetti and M. Corazza, Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients, Journal of the European Academy of Dermatology and Venereology, 28, 7, (943-948), (2013).
- Nicholas Wedel and Laura Johnson, Vulvar Lichen Sclerosus: Diagnosis and Management, The Journal for Nurse Practitioners, 10.1016/j.nurpra.2013.10.009, 10, 1, (42-48), (2014).
- Brooks Brodrick, Zoe R. Belkin and Andrew T. Goldstein, Influence of treatments on prognosis for vulvar lichen sclerosus: Facts and controversies, Clinics in Dermatology, 31, 6, (780), (2013).
- Susanna K. Fistarol and Peter H. Itin, Diagnosis and Treatment of Lichen Sclerosus, American Journal of Clinical Dermatology, 14, 1, (27), (2013).
- Jennifer Bradford and Gayle Fischer, Surgical Division of Labial Adhesions in Vulvar Lichen Sclerosus and Lichen Planus, Journal of Lower Genital Tract Disease, 17, 1, (48), (2013).
- Sara Pinelli, Angelo Massimiliano D'Erme and Torello Lotti, Management of sexual dysfunction due to vulvar lichen sclerosus in postmenopausal women, Dermatologic Therapy, 26, 1, (79-82), (2013).
- Jennifer Bradford and Gayle Fischer, Management of Vulvovaginal Lichen Planus, Journal of Lower Genital Tract Disease, 17, 1, (28), (2013).
- Faustino R. Pérez-López, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Irene Lambrinoudaki, Margaret Rees, Karin Schenck-Gustafsson, Florence Tremollieres, Yvonne T. van der Schouw and Tommaso Simoncini, EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women, Maturitas, 74, 3, (279), (2013).
- Lois J. Eva, Screening and follow up of vulval skin disorders, Best Practice & Research Clinical Obstetrics & Gynaecology, 26, 2, (175), (2012).
- Katrina Alef Thorstensen and Debra L. Birenbaum, Recognition and Management of Vulvar Dermatologic Conditions: Lichen Sclerosus, Lichen Planus, and Lichen Simplex Chronicus, Journal of Midwifery & Women's Health, 57, 3, (260-275), (2012).
- Mahalakshmi Gurumurthy, Nneka Morah, Giorgio Gioffre and Margaret E. Cruickshank, The surgical management of complications of vulval lichen sclerosus, European Journal of Obstetrics & Gynecology and Reproductive Biology, 162, 1, (79), (2012).
- Andreas R. Günthert, Kathleen Duclos, Boriana G. Jahns, Elke Krause, Esther Amann, Andreas Limacher, Michael D. Mueller and Peter Jüni, Clinical Scoring System for Vulvar Lichen Sclerosus, The Journal of Sexual Medicine, 9, 9, (2342-2350), (2012).
- Antonietta D'Antuono, Sara Bellavista, Francesca Negosanti, Stefania Zauli, Elena Baldi and Annalisa Patrizi, Dermasilk Briefs in Vulvar Lichen Sclerosus, Journal of Lower Genital Tract Disease, 15, 4, (287), (2011).
- Rowena Meani, Anne Howard and Emma Veysey, Incidence of vulval squamous cell carcinoma in women with vulval lichen sclerosus in an Australian tertiary referral centre, Australasian Journal of Dermatology, , (2018).




